Home > Investor Centre

Investor Centre

Information about our corporate activities for current shareholders and potential investors.

Corum Group Limited is an Australian-owned, publicly listed company. Corum Group shares are listed on the Australian Securities Exchange (ASX) and are traded under the code COO. The company’s financial year runs from 1 July to 30 June, with half-year results announced in February and the full year results announced in August each year.

Announcements

Corum Agrees Sale of eCommerce Business Unit 20 December 2021530
Notification regarding unquoted securities - COO 10 December 2021529
Trading Update 8 December 2021528
Update on Legal Proceedings relating to PharmX 7 December 2021527
Results of Annual General Meeting 24 November 2021526
Chairman & CEO Address and AGM Presentation 24 November 2021525
Key Retail Pharmacy Groups signed on to drive PharmX growth 23 November 2021524
Corum Trading Update 29 October 2021523
Notice of General Meeting/Proxy Form 22 October 2021522
2021 Annual General Meeting Key Dates 10 September 2021521
Corum extends relationship with Sigma into WholeLife 2 September 2021520
Press Release and Investor Presentation 18 August 2021517
Appendix 4E and Annual Report 18 August 2021516
Appendix 4G and Corporate Governance Statement 18 August 2021515
Notice of Results Announcement and Investor Presentation 10 August 2021503
Investor Presentation 3 August 2021502
Quarterly Activity Report and Appendix 4C 30 July 2021501
Notification of cessation of securities - COO 14 July 2021500
Update on Legal Proceedings 14 May 2021499
Change of Share Registry 23 April 2021498
Quarterly Activities Report and Appendix 4C 22 April 2021497
H1 FY21 Interim Media Release and Results Presentation 24 February 2021496
Half Yearly Report and Accounts 24 February 2021495
HY 21 Reporting Date and Investor Presentation 17 February 2021494
Quarterly Activities Report and Appendix 4C 29 January 2021493
Change of Director’s Interest Notice Newbery 15 December 2020492
Change of Director’s Interest Notice Shaw 10 December 2020491
Initial Director’s Interest Notice Bastas 9 December 2020489
Becoming a substantial holder Bastas 9 December 2020490
Change of Director’s Interest Notice Shaw 8 December 2020488
Show More
Appointment of Dennis Bastas as Director 3 December 2020487
Change of Director’s Interest Notice 1 December 2020486
Change of Director’s Interest Notice 30 November 2020485
Proposed Issue of Securities - COO 19 November 2020484
Results of Meeting 17 November 2020482
CEO’s Address to Shareholders 17 November 2020481
Chairman’s Address to Shareholders 17 November 2020480
Release of ordinary shares from escrow 10 November 2020479
Cleansing Notice 6 November 2020478
Appendix 2A 6 November 2020477
Proposed issue of Securities - COO 6 November 2020483
Arrotex Pharmaceuticals becomes strategic shareholder 6 November 2020476
Trading Halt 5 November 2020475
Corum New Company Secretary Appointment 3 November 2020474
Update on BAMM Agreement 30 October 2020473
Appendix 4C - quarterly 30 October 2020472
Initial Director’s Interest Notice 20 October 2020471
Notice of Annual General Meeting and Explanatory Memorandum 16 October 2020466
Jayne Shaw Joins Corum Board 15 October 2020470
Change of Director’s Interest Notice 5 October 2020469
Change of Director’s Interest Notice 2 October 2020468
Becoming a substantial holder from AEF 1 October 2020467
2020 Annual General Meeting Update 30 September 2020464
Appendix 2A 29 September 2020463
Cleansing Statement 29 September 2020462
Completion of $5.6m Capital Raising 28 September 2020461
Entitlement Offer - Extension of Closing date 15 September 2020460
Indicative Timetable of Key Dates 10 September 2020459
Despatch of Offer Booklet 9 September 2020458
Update - Proposed issue of Securities 4 September 2020457
Appendix 3Z Final Director’s Interest 4 September 2020456
Corum Announces Completion of PharmX Acquisition 4 September 2020455
Investor Presentation September 2020 1 September 2020454
Entitlement Offer Letter to Ineligible Shareholders 1 September 2020453
Proposed issue of Securities - COO 1 September 2020452
Offer Booklet 1 September 2020451
Cleansing Statement 1 September 2020450
Acquisition of Remaining 57% interest in PharmX 1 September 2020449
Corum New Company Secretary Appointment 1 September 2020448
Corum Executive Management Changes 1 September 2020447
Trading Halt 31 August 2020446
Appendix 4G & Corporate Governance Statement 24 August 2020444
Appendix 4E and Annual Report 24 August 2020443
Corum Group Annual Report 2020 24 August 2020439
Appendix 3B - Performance Rights Issues 21 August 2020438
Change of Auditor - Audit Practice Restructure 21 August 2020437
Appendix 4C - quarterly 7 August 2020436
Update on BAMM Agreement 30 June 2020435
Initial Director’s Interest Notice 16 April 2020433
Director Appointment 16 April 2020432
Director Resignation and Final Director’s Interest Notice 6 April 2020431
Appendix 4C - quarterly 1 April 2020434
Corum to increase ownership in PharmX 24 March 2020430
Change of Director’s Interest Notice 4 March 2020429
Change of Director’s Interest Notice 4 March 2020428
Initial Director’s Interest Notice 2 March 2020427
Director Appointment 25 February 2020426
Director Resignation and Final Directors Interest Notice 24 February 2020425
Initial Director’s Interest Notice 19 February 2020424
Final Director’s Interest Notice 19 February 2020423
Chairman Retirement 19 February 2020422
Half Yearly Report and Accounts 18 February 2020421
Management Incentive Plan 18 February 2020420
Appendix 4C - quarterly 31 January 2020419
Update on Court Proceedings 23 December 2019418
Ceasing to be a substantial holder 6 December 2019417
Board Succession 2 December 2019416
Ceasing to be a substantial holder 26 November 2019415
Investor Group Substantial shareholder notice 603 21 November 2019413
Director Appointment 21 November 2019412
Completion of Share Placement 21 November 2019411
Cleansing Statement Section708A(5)(e) 21 November 2019410
Change in substantial holding 21 November 2019409
Initial director’s Interest Notice 21 November 2019408
Appendix 3B - Capital Raise 21 November 2019407
AGM Results Poll 20 November 2019406
Ceasing to be Substantial shareholder notice change 605 20 November 2019405
Chairman’s Address 20 November 2019404
Waiver From Listing Rule 7.3.2 12 November 2019400
Addendum to Notice of Annual General Meeting 11 November 2019399
Response to ASX price query 8 November 2019398
Appendix 4C Quarterly 31 October 2019387
Notice of Annual General Meeting & Proxy Form 18 October 2019397
Directorship 18 October 2019386
Corum secures strategic partnership 11 October 2019396
Substantial holder notice 8 October 2019395
Corum structured for growth 27 September 2019394
Trading Halt 25 September 2019393
SaaS technolgy collaboration agreement 24 September 2019392
Appendix 4G and Corporate Governance Statement 29 August 2019385
Appendix 4E and Annual Report 29 August 2019384
Results of EGM 25 February 2019390
Half Yearly Results Announcement 22 February 2019389
Half Yearly Results and Accounts 22 February 2019388
Notice of EGM / Proxy Form 18 February 2019382
Corum Clear Dispense Update 26 January 2019391
EGM ASX Waiver 25 January 2019383
AGM Chair and CEO Address 28 November 2018381
Results of Annual General Meeting 28 November 2018380
Notice of Annual General Meeting and Explanatory Memorandum 26 October 2018379
Appendix 4E Preliminary final report 29 August 2018375
Corum Clear Update 20 July 2018374
Half Yearly Report and Accounts 28 February 2018373
Corum signs up to My Health Record 29 November 2017370
Results of Meeting 29 November 2017369
Chairman and CEO Address to Shareholders 29 November 2017368
Notice of Annual General Meeting/Proxy Form 27 October 2017367
Annual Report to shareholders 27 October 2017366
Appendix 4G - Corporate Governance 1 September 2017365
Appendix 4E and Annual Accounts 31 August 2017364
Corum announces expected non-cash impairment 25 August 2017363
Change of Director’s Interest Notice 20 March 2017362
Half Yearly Report and Accounts 24 February 2017361
Half-Year Report Investor Update 24 February 2017360
Appointment of Chief Executive Officer 24 January 2017358
Appendix 3B - Exercise of Performance Rights 13 December 2016359
Chairman’s Address to Shareholders 2 November 2016357
Results of Meeting 2 November 2016356
Annual Report to shareholders 30 September 2016352
Notice of General Meeting/Proxy Form 30 September 2016351
Change of Director’s Interest Notice 20 September 2016353
Change of Director’s Interest Notice 15 September 2016354
Change of Director’s Interest Notice 9 September 2016355
Appendix 4E and Annual Report 31 August 2016348
Appendix 4G - Corporate Governance 31 August 2016347
Trading Update 13 July 2016343
Chief Executive Officer Appointment 11 March 2016344
Change of Director’s Interest Notice 9 March 2016345
Change of Director’s Interest Notice 3 March 2016332
Half Yearly Report and Accounts 29 February 2016335
Company Update 29 February 2016334
Reinstatement to Official Quotation 29 February 2016333
Suspension from Official Quotation 25 February 2016336
Trading Halt 23 February 2016337
Appointment of Executive Director 11 January 2016338
Response to ASX Price Query 29 December 2015339
Change of Director’s Interest Notice 10 December 2015340
Change of Director’s Interest Notice 26 November 2015342
Change of Director’s Interest Notice 26 November 2015341
Chairman’s Address to Shareholders 19 November 2015330
Results of Meeting 19 November 2015329
Director Appointment/Resignation 2 November 2015328
Final Director’s Interest Notice 2 November 2015327
Final Director’s Interest Notice 2 November 2015326
Managing Director / CEO Resignation 28 October 2015320
Appendix 3B - Exercise of Performance Rights 26 October 2015321
Annual Report to shareholders 19 October 2015324
Notice of Annual General Meeting/Proxy Form 19 October 2015323
Appendix 4G - Key to Corporate Governance Disclosures 19 October 2015322
Final Director’s Interest Notice 28 August 2015316
Preliminary Final Report 27 August 2015319
FY15 Results Announcement 27 August 2015318
FY15 Company Presentation 27 August 2015317
Director Appointment 21 August 2015315
Initial Director’s Interest Notice 21 August 2015314
Director Resignation 19 August 2015312
Details of Company Address 18 August 2015313
Appendix 3B - Employee Share Scheme 3 July 2015311
Managing Director / CEO appointments and contract terms 19 June 2015306
Performance Rights Lapse 5 June 2015307
Chairman and Director Appointments 20 May 2015309
Initial Director’s Interest Notice 20 May 2015308
Initial Director’s Interest Notice 1 May 2015310
Director Appointment / Company Secretary Resignation 27 April 2015305
Appendix 4C - quarterly and commentary 27 April 2015304
Final Director’s Interest Notice 10 April 2015284
Chairman Retirement 2 April 2015285
Director Appointment 20 March 2015287
Initial Director’s Interest Notice 20 March 2015286
Acting MD / CEO - Terms of Appointment 19 March 2015288
Response to ASX Query 24 February 2015289
Company Secretary Appointment 20 February 2015290
Half Yearly Report and Accounts 18 February 2015291
Final Director’s Interest Notice 13 February 2015292
Change in Managing Director / Chief Executive Officer 30 January 2015293
Appendix 4C - quarterly 28 January 2015295
Dividend Declaration 28 January 2015294
Expiry of Employee Share Options 16 December 2014296
Appendix 3B - exercise of options 15 December 2014297
Appendix 3B - exercise of options 27 November 2014298
Chairman’s Address to Shareholders 19 November 2014300
Results of Meeting 19 November 2014299
Notice of General Meeting/Proxy Form 17 October 2014301
Appendix 4C - quarterly 15 October 2014302
Show Less

 

© 2022 Corum Group Pty Ltd  |  Privacy Policy  |  Terms of Use